These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

263 related articles for article (PubMed ID: 38781120)

  • 1. Mitotic deacetylase complex (MiDAC) recognizes the HIV-1 core promoter to control activated viral gene expression.
    Wilhelm E; Poirier M; Da Rocha M; Bédard M; McDonald PP; Lavigne P; Hunter CL; Bell B
    PLoS Pathog; 2024 May; 20(5):e1011821. PubMed ID: 38781120
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CTGC motifs within the HIV core promoter specify Tat-responsive pre-initiation complexes.
    Wilhelm E; Doyle MC; Nzaramba I; Magdzinski A; Dumais N; Bell B
    Retrovirology; 2012 Jul; 9():62. PubMed ID: 22834489
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Semen Exosomes Promote Transcriptional Silencing of HIV-1 by Disrupting NF-κB/Sp1/Tat Circuitry.
    Welch JL; Kaddour H; Schlievert PM; Stapleton JT; Okeoma CM
    J Virol; 2018 Nov; 92(21):. PubMed ID: 30111566
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Splicing Factor 3B Subunit 1 Interacts with HIV Tat and Plays a Role in Viral Transcription and Reactivation from Latency.
    Kyei GB; Meng S; Ramani R; Niu A; Lagisetti C; Webb TR; Ratner L
    mBio; 2018 Nov; 9(6):. PubMed ID: 30401776
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A Stronger Transcription Regulatory Circuit of HIV-1C Drives the Rapid Establishment of Latency with Implications for the Direct Involvement of Tat.
    Chakraborty S; Kabi M; Ranga U
    J Virol; 2020 Sep; 94(19):. PubMed ID: 32669338
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Molecular Basis for Human Immunodeficiency Virus Latency.
    Mbonye U; Karn J
    Annu Rev Virol; 2017 Sep; 4(1):261-285. PubMed ID: 28715973
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Selective recognition of viral promoters by host cell transcription complexes: challenges and opportunities to control latency.
    Wilhelm E; Bell B
    Curr Opin Virol; 2013 Aug; 3(4):380-6. PubMed ID: 23827503
    [TBL] [Abstract][Full Text] [Related]  

  • 8. HIV latency reversing agents act through Tat post translational modifications.
    Khoury G; Mota TM; Li S; Tumpach C; Lee MY; Jacobson J; Harty L; Anderson JL; Lewin SR; Purcell DFJ
    Retrovirology; 2018 May; 15(1):36. PubMed ID: 29751762
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A chalcone derivative reactivates latent HIV-1 transcription through activating P-TEFb and promoting Tat-SEC interaction on viral promoter.
    Wu J; Ao MT; Shao R; Wang HR; Yu D; Fang MJ; Gao X; Wu Z; Zhou Q; Xue YH
    Sci Rep; 2017 Sep; 7(1):10657. PubMed ID: 28878233
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Transition step during assembly of HIV Tat:P-TEFb transcription complexes and transfer to TAR RNA.
    D'Orso I; Jang GM; Pastuszak AW; Faust TB; Quezada E; Booth DS; Frankel AD
    Mol Cell Biol; 2012 Dec; 32(23):4780-93. PubMed ID: 23007159
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Probabilistic control of HIV latency and transactivation by the Tat gene circuit.
    Cao Y; Lei X; Ribeiro RM; Perelson AS; Liang J
    Proc Natl Acad Sci U S A; 2018 Dec; 115(49):12453-12458. PubMed ID: 30455316
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of Host Factors on the Regulation of Tat-Mediated HIV-1 Transcription.
    Mousseau G; Valente ST
    Curr Pharm Des; 2017; 23(28):4079-4090. PubMed ID: 28641539
    [TBL] [Abstract][Full Text] [Related]  

  • 13. HEXIM1-Tat chimera inhibits HIV-1 replication.
    Leoz M; Kukanja P; Luo Z; Huang F; Cary DC; Peterlin BM; Fujinaga K
    PLoS Pathog; 2018 Nov; 14(11):e1007402. PubMed ID: 30395647
    [TBL] [Abstract][Full Text] [Related]  

  • 14. UHRF1 Suppresses HIV-1 Transcription and Promotes HIV-1 Latency by Competing with p-TEFb for Ubiquitination-Proteasomal Degradation of Tat.
    Liang T; Zhang Q; Wu Z; Chen P; Huang Y; Liu S; Li L
    mBio; 2021 Aug; 12(4):e0162521. PubMed ID: 34465029
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An emerging and variant viral promoter of HIV-1 subtype C exhibits low-level gene expression noise.
    Ali H; Bhange D; Mehta K; Gohil Y; Prajapati HK; Byrareddy SN; Buch S; Ranga U
    Retrovirology; 2021 Sep; 18(1):27. PubMed ID: 34538278
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Posttranscriptional Regulation of HIV-1 Gene Expression during Replication and Reactivation from Latency by Nuclear Matrix Protein MATR3.
    Sarracino A; Gharu L; Kula A; Pasternak AO; Avettand-Fenoel V; Rouzioux C; Bardina M; De Wit S; Benkirane M; Berkhout B; Van Lint C; Marcello A
    mBio; 2018 Nov; 9(6):. PubMed ID: 30425153
    [TBL] [Abstract][Full Text] [Related]  

  • 17. BET bromodomain-targeting compounds reactivate HIV from latency via a Tat-independent mechanism.
    Boehm D; Calvanese V; Dar RD; Xing S; Schroeder S; Martins L; Aull K; Li PC; Planelles V; Bradner JE; Zhou MM; Siliciano RF; Weinberger L; Verdin E; Ott M
    Cell Cycle; 2013 Feb; 12(3):452-62. PubMed ID: 23255218
    [TBL] [Abstract][Full Text] [Related]  

  • 18. NF-kappaB p50 promotes HIV latency through HDAC recruitment and repression of transcriptional initiation.
    Williams SA; Chen LF; Kwon H; Ruiz-Jarabo CM; Verdin E; Greene WC
    EMBO J; 2006 Jan; 25(1):139-49. PubMed ID: 16319923
    [TBL] [Abstract][Full Text] [Related]  

  • 19. HMGA1 directly interacts with TAR to modulate basal and Tat-dependent HIV transcription.
    Eilebrecht S; Wilhelm E; Benecke BJ; Bell B; Benecke AG
    RNA Biol; 2013 Mar; 10(3):436-44. PubMed ID: 23392246
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Tat/P-TEFb Protein-Protein Interaction Determining Transcriptional Activation of HIV.
    Asamitsu K; Okamoto T
    Curr Pharm Des; 2017; 23(28):4091-4097. PubMed ID: 28699519
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.